Elyse Stock, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 57,716 shares at $106.17 ($6.1M) on 2021-12-15, disclosed to the SEC on 2021-12-16.
Open-market sale of $6.1M BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.02 | 6,939 | $729K | 12.0% |
| 2 | $105.02 | 6,939 | $729K | 12.0% |
| 3 | $105.43 | 20,330 | $2.1M | 35.2% |
| 4 | $105.43 | 20,330 | $2.1M | 35.2% |
| 5 | $106.17 | 1,589 | $169K | 2.8% |
| 6 | $106.17 | 1,589 |
| $169K |
| 2.8% |
| Total | $105.37 avg | 57,716 | $6.1M | 100% |
| Filing → |
| BHVN | SELL | 2019-10-17 | $36K | — | Filing → |